Vetigenics (vetigenics.com): no confident changes recorded yet; website history since November 2026. Homepage last checked 6 November 2026.
First recorded website
Observed 6 November 2026
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Clinical Trials and Monoclonal Antibody for Dogs
Vetigenics is a pet biotech company pioneering monoclonal antibody therapies and clinical trials for dogs with cancer. Explore pet cancer treatment options and drug development.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
Recorded changes
Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
No changes recorded yet. Missing observations do not mean the company has not changed.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingClinical Trials and Monoclonal Antibody for Dogs
Vetigenics is a pet biotech company pioneering monoclonal antibody therapies and clinical trials for dogs with cancer. Explore pet cancer treatment options and drug development.